Meeting plenary session to feature 12-Month data from MIRROR randomized controlled trial of KRYSTEXXA (pegloticase) injection with methotrexate - Horizon Therapeutics plc (Nasdaq: HZNP) today announced
Intervention with methotrexate in patients with arthralgia at risk of rheumatoid arthritis to reduce the development of persistent arthritis and its disease burden (TREAT EARLIER): a randomised, double-blind, placebo-controlled, proof-of-concept trial thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Amgen (NASDAQ:AMGN) today announced financial results for the fourth quarter and full year 2021 versus comparable periods in 2020. Key results.
The FDA has approved secukinumab for the treatment of active psoriatic arthritis in patients aged 2 years and older, and for active enthesitis-related arthritis in those aged 4 years and older.The announcement, issued Dec. 22, makes secukinumab (Cosentyx, Novartis) the first biologic indicated for enthesitis-related arthritis, and the only biologic agent approved for both enthesitis-related
The keto diet, a high-fat eating plan, is not ideal for people with rheumatoid arthritis or other inflammatory conditions. Some foods help fight inflammation.